Clinical Trials Logo

Clinical Trial Summary

Measurement of clusterin level in the semen of infertile males undergoing testicular sperm extraction.


Clinical Trial Description

Clusterin, known as apolipoprotein J, sulphated glycoprotein-2 or testosterone - repressed prostate message-2. It plays important roles in several pathophysiological processes, including tissue remodelling, lipid transport, reproduction, complement regulation and apoptotic cell death . As clusterin expression is markedly upregulated in various normal and malignant tissues undergoing apoptosis, it has been regarded as a marker for cell death. There is a conflicting findings concerning the relationship between elevated clusterin expression and enhanced induction of apoptosis; that is, clusterin has appeared to have a powerful anti-apoptotic function through a chaperone-like activity. In addition to the anti-apoptotic activity, seminal clusterin was reported to promote a tolerogenic response to male antigens, thereby contributing to female tolerance to seminal antigens. In the testis, clusterin is secreted by Sertoli cells into the fluid of the seminiferous epithelium and deposited onto the membranes of elongating spermatids and mature spermatozoa. To date, however, there has been little information with respect to the functional roles of clusterin in the male reproductive tract under physiological conditions. In particular, it remains controversial as to whether or not clusterin helps assist the normal spermatogenesis. Nonobstructive azoospermia (NOA) males are characterised by impaired spermatogenesis. Although NOA patients have impaired global spermatogenic function, focal areas of spermatogenesis may still exist in their testes. Focal spermatogenesis could possibly be obtained by testicular sperm extraction (TESE) technique . A number of factors have been suggested to be of predictive value for patients with a good chance to retrieve sperm cell such as testicular volume, serum FSH levels , serum total testosterone and serum inhibin B levels. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03857828
Study type Observational
Source Assiut University
Contact Azza Sheshaey, M.B.B.CH
Phone 01096906812
Email azzaandel@yahoo.com
Status Not yet recruiting
Phase
Start date December 16, 2020
Completion date May 1, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03146260 - TESE and Non Obstructive Azoospermia N/A
Recruiting NCT03809026 - The Potential of Sperm Retrieved by Micro-TESE to Fertilize Vitrified/Warmed Oocytes
Active, not recruiting NCT03291522 - Retrieval of Sperm From Men With Azoospermia Using Ultrasound-guided Rete Testis Aspiration
Completed NCT05483621 - Hormonal Stimulation of Spermatogenesis Phase 1
Completed NCT06358794 - Machine Learning Based-Personalized Prediction of Sperm Retrieval Success Rate
Recruiting NCT06181851 - 2015-Metabolomics&Microbiome-infertility
Completed NCT04237779 - The Effects of Intratesticular PRP Injection in Men With Azoospermia or Cryptozoospermia N/A
Not yet recruiting NCT03615547 - Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells Phase 3
Completed NCT04397887 - Seminal TEX101 as a Predictor of Recovery of Spermatogenesis in Azoospermic Men With Palpable Varicocele N/A
Completed NCT02900105 - Effect of Letrozole on Seminal Parameters in Men With Non Obstructive Azoospermia and Severe Oligozoospermia. Phase 3